Results 271 to 280 of about 98,962 (385)

Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry [PDF]

, 2009
Igor A. Kaltashov, Cedric E. Bobst, Rinat R. Abzalimov, Steven A. Berkowitz, Damian J. Houde   +4 more
openalex   +1 more source

Sustainability impacts for converting to Raman spectroscopy inline monitoring from traditional offline manual sampling in small‐scale and large‐scale biomanufacturing

Journal of Chemical Technology &Biotechnology, EarlyView.
Abstract As biomanufacturing evolves to meet environmental goals, adopting innovative analytical technologies creates new pathways for sustainable process control. This study examines the impact of replacing traditional offline manual sampling with inline Raman spectroscopy for monitoring critical bioprocess parameters in both small‐ and large‐scale ...
Stacy Simon, Phyllis Pugh, Preeya Boppana, Zahra Allen, Jenna Lemons, Veera Padmanabhan   +5 more
wiley   +1 more source

In Vitro Silencing of MHC-I in Keratinocytes by Herpesvirus US11 Protein to Model Alloreactive Suppression. [PDF]

Eur Burn J
Schlottmann F, Strauß S, Vogt PM, Bucan V.   +3 more
europepmc   +1 more source

Biopharmaceutical Protein Production under Controlled Environments: Growth, Development, and Vaccine Productivity of Transgenic Tomato Plants Grown Hydroponically in a Greenhouse [PDF]

, 2009
Ryo Matsuda, Chieri Kubota, M. Lucrecia Alvarez, Guy A. Cardineau   +3 more
openalex   +1 more source

Development of a step‐gradient simulated moving bed process for the polishing of monoclonal antibodies with anion exchange chromatography

Journal of Chemical Technology &Biotechnology, EarlyView.
Abstract BACKGROUND In recent years, biopharmaceutical applications in medicine have seen explosive growth and the need for efficient, rapid and inexpensive purification of these targets is the topic of tremendous research and development. The need to improve process efficiency has been an active area of investigation due to the tremendous potential ...
Yasmina MJ Harsy, Jonas Wege, Anthony Grabski, Romain Dabre, Egbert Müller, Carsten‐René Arlt   +5 more
wiley   +1 more source

Increasing early phase clinical trials capacity in India. [PDF]

Commun Med (Lond)
Cherian JJ, Poomali A, Mukherjee A, Gupta TM, Medhi B, Mukherjee S, Sankaranarayanan A, Saha N, Gota V, Gudde RS, Pahuja M, Das S, Chatterjee NS, Bose R, Kshirsagar N, Raghuvanshi RS.   +15 more
europepmc   +1 more source

Biosimilars and biopharmaceuticals: what the nephrologist needs to know--a position paper by the ERA-EDTA Council [PDF]

, 2009
Stanley Shaldon
openalex   +1 more source

A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for pediatric use

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) presents before age 20 years in ~25% of patients. Regulatory approvals of IBD medications for pediatric use are often delayed. Nevertheless, many pediatric patients receive medication not approved for pediatric use.
Courtney Rusch, Anthony J. Perkins, Steven J. Steiner, the ImproveCareNow Pediatric IBD Learning Health System   +3 more
wiley   +1 more source

Disease Biomarkers in the Precision Medicine Era: A Comprehensive Multi-Omics Analysis. [PDF]

Biomedicines
Chen PH, Yong SB, Yii CY, Li CJ.
europepmc   +1 more source

Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: a Review

Journal of Pharmaceutical Innovation, 2019
O. Yang, Maen Qadan, M. Ierapetritou
semanticscholar   +1 more source